Tuesday, July 08, 2008
« Lighting and Optical Tools for Image For... | Main | The Journal of Web Librarianship »
FDA notified healthcare professionals that a BOXED WARNING and Medication Guide are to be added to the prescribing information to strengthen existing warnings about the increased risk of developing tendinitis and tendon rupture in patients taking fluoroquinolones for systemic use.

This risk of tendinitis and tendon rupture is further increased in those over age 60, in kidney, heart, and lung transplant recipients, and with use of concomitant steroid therapy. Physicians should advise patients, at the first sign of tendon pain, swelling, or inflammation, to stop taking the fluoroquinolone, to avoid exercise and use of the affected area, and to promptly contact their doctor about changing to a non-fluoroquinolone antimicrobial drug. Selection of a fluoroquinolone for the treatment or prevention of an infection should be limited to those conditions that are proven or strongly suspected to be caused by bacteria.

Read the complete MedWatch 2008 Safety Summary, including a link to the 'Information for Healthcare Professionals' page, at:

http://www.fda.gov/medwatch/safety/2008/safety08.htm#Fluoroquinolone

Tuesday, July 08, 2008 11:38:19 AM (Pacific Daylight Time, UTC-07:00)    Disclaimer  |   |  Related posts:
The Bipartisan Breast Cancer Patient Protection Act Needs Your Support!
Found Genetic link to PTSD
How do I use and find and create Twitter Lists
Map of Cuauhtinchan links Mexican Americans Chicano People with their past
Navajo Code Talker Willard V. Oliver passes on
Toxic Plastic numbers